Study backs Vasomedical's EECP (external counterpulsation) heart failure therapy
This article was originally published in Clinica
Executive Summary
Evidence is growing to support Vasomedical's noninvasive external counterpulsation (EECP) therapy, after a study showed the technology was able to significantly improve cardiac output and quality of life in patients with congestive heart failure (CHF).